Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE The rs9939609 polymorphism in the FTO gene has recently been implicated as a risk factor for some types of cancer, such as breast, pancreatic, and prostate cancers. 29260910

2018

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE The study objective was to assess the prevalence of cardiovascular disease risk factors in patients treated for childhood cancer (<i>N</i> = 101) and to determine the involvement of clinical (cancer type and therapy) and/or genetic (<i>FTO</i> gene rs9939609 polymorphism) factors. 29675043

2018

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE Besides, in the subgroup analysis of ethnicity, our results indicated that rs9939609 polymorphism was significantly associated with cancer risk in Asians. 26931363

2017

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE However, <i>FTO</i> rs9939609 variant was associated with some types of cancer in the subgroup analysis. 28881622

2017

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation GWASCAT Pleiotropic Meta-Analyses of Longitudinal Studies Discover Novel Genetic Variants Associated with Age-Related Diseases. 27790247

2016

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE Variants (such as rs9939609) in the fat mass- and obesity-associated (FTO) gene have been associated with obesity, type 2 diabetes, some cancers, and alcohol consumption. 23771786

2013

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE Our meta-analysis indicated that there was no association between FTO rs9939609 polymorphism and the increased risk of cancer, although this polymorphism was marginally associated with pancreatic cancer. 22396042

2012

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE Among 22,799 individuals (44-74 years) in the population-based Malmö diet and cancer cohort that were genotyped for rs9939609 in FTO and had information on dietary intake (from a modified diet history method) and no history of diabetes, cancer or cardiovascular disease, 2255 deaths (including 1100 cancer and 674 cardiovascular deaths) occurred during 12.0 years of follow-up. 21179003

2011

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE The rs9939609 A allele, which was associated with higher BMI in the sample, was inversely associated with overall (odds ratio (OR) versus all controls  = 0.93; 95% confidence interval (CI): 0.85-1.02 p = 0.12 per allele) and low-grade (OR = 0.90; 0.81-0.99 p = 0.03 per allele) prostate cancer risk, but positively associated with high-grade cancer among cases (OR high- versus low-grade cancer  = 1.16; 0.99-1.37 p = 0.07 per allele). 20976066

2010

dbSNP: rs9939609
rs9939609
FTO
0.790 GeneticVariation BEFREE A cross-sectional study examined 4839 subjects in the population-based Malmö Diet and Cancer study with dietary data (from a modified diet history method) and information on the genetic variant FTO (rs9939609). 19726594

2009

dbSNP: rs1800625
rs1800625
0.720 GeneticVariation BEFREE CONCLUSIONS In conclusion, the RAGE rs1800625 polymorphism was associated with increased overall cancer risk in Asians in recessive genetic model. 31534114

2019

dbSNP: rs1800625
rs1800625
G 0.720 GeneticVariation GWASCAT HLA-B*57:01 Confers Susceptibility to Pazopanib-Associated Liver Injury in Patients with Cancer. 26546620

2016

dbSNP: rs1800625
rs1800625
0.720 GeneticVariation BEFREE Therefore, we performed a systematic review to identify statistical evidence of the association between the 3 polymorphisms rs2070600 G/S (82G>S), rs1800624 T/A ( -374 T>A) and rs1800625C/T (-429 C>T) and the risk of cancer. 26011358

2015

dbSNP: rs1800625
rs1800625
0.720 GeneticVariation BEFREE We failed to get an effective conclusion about the association between the rs1800624 and rs1800625 polymorphisms and cancer risk in overall comparison. 26011358

2015

dbSNP: rs12494691
rs12494691
A 0.700 GeneticVariation GWASCAT Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study. 30277654

2018

dbSNP: rs1641025
rs1641025
T 0.700 GeneticVariation GWASCAT Gamma-aminobutyric acid transaminase genetic polymorphism is a candidate locus for responsiveness to opioid analgesics in patients with cancer pain: An exploratory study. 30277654

2018

dbSNP: rs10035650
rs10035650
0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10138053
rs10138053
C 0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10160246
rs10160246
A 0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10273639
rs10273639
T 0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs1029966
rs1029966
T 0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10490913
rs10490913
0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10510776
rs10510776
0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10833965
rs10833965
A 0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017

dbSNP: rs10854373
rs10854373
C 0.700 GeneticVariation GWASCAT Cancer risk susceptibility loci in a Swedish population. 29299148

2017